Development of a Single-Chain Fragment Variable that Binds to the SARS-CoV-2 Spike Protein Produced by Genetically Modified Lactic Acid Bacteria
-
Published:2023-04-15
Issue:1
Volume:66
Page:151-160
-
ISSN:1073-6085
-
Container-title:Molecular Biotechnology
-
language:en
-
Short-container-title:Mol Biotechnol
Author:
Oshima Suzuka, Namai Fu, Sato Takashi, Shimosato TakeshiORCID
Funder
Japan Society for the Promotion of Science Interdisciplinary Cluster for Cutting Edge Research, Shinshu University
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,Bioengineering,Biotechnology
Reference32 articles.
1. WHO (2022) COVID-19 weekly epidemiological update, edition 119, 23 November 2022 2. Florindo, H. F., Kleiner, R., Vaskovich-Koubi, D., Acurcio, R. C., Carreira, B., Yeini, E., Tiram, G., Liubomirski, Y., & Satchi-Fainaro, R. (2020). Immune-mediated approaches against COVID-19. Nature Nanotechnology, 15, 630–645. 3. V’Kovski, P., Kratzel, A., Steiner, S., Stalder, H., & Thiel, V. (2021). Coronavirus biology and replication: Implications for SARS-CoV-2. Nature Reviews Microbiology, 19, 155–170. 4. Luo, D., Li, T., Yang, X., Ning, N., Zhang, L., Gu, H., Li, D., Yu, W., Hu, Z., & Wang, H. (2022). The immunodominance of RBD antigen of delta variant as vaccine candidate against SARS-CoV-2 infection. Journal of Medical Virology, 95, e28359. https://doi.org/10.1002/jmv.28359 5. Ji, Y., Zhang, Q., Cheng, L., Ge, J., Wang, R., Fang, M., Mucker, E. M., Chen, P., Ma, J., Zhang, R., Li, C., Hammond, H., Baracco, L., Holbrook, M., Frieman, M., Zhang, Z., Wang, X., Hooper, J. W., Zhang, L., & Zhu, Q. (2022). Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2. Frontiers in Immunology, 13, 980435.
|
|